Oyster Point Pharma

PharmaceuticalsSeries BPrinceton, USoysterpointrx.com

Latest round

Series B

Last raised

Feb 2019

Total raised

$114M

Investors

6

About Oyster Point Pharma

Oyster Point Pharma, Inc.Founded in 2015 and headquartered in Princeton, US, Oyster Point Pharma, Inc. specializes in ocular therapeutics. In November 2022, Viatris Inc. agreed to acquire all outstanding shares of Oyster Point Pharma at USD 11 per share, with a potential additional payment contingent on performance.Oyster Point Pharma focuses on developing therapies for dry eye disease, notably its flagship product, TYRVAYA.Following the recent acquisition by Viatris, Oyster Point Pharma plans to leverage new resources to enhance the launch and distribution of TYRVAYA. The company aims to expand its product offerings and increase its market penetration in the US and other international markets.

Who invested in Oyster Point Pharma

6 investors across 2 rounds

See all investors in Oyster Point Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 15, 2019

    Amount

    $85M

    Investors

    Locked

  2. Series A

    Oct 11, 2017

    Amount

    $29M

    Investors

    Locked

Questions about Oyster Point Pharma

Who invested in Oyster Point Pharma?

Oyster Point Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Oyster Point Pharma raised?

Oyster Point Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Oyster Point Pharma last raise money?

Oyster Point Pharma's most recent round on record is a Series B, in Feb 2019.

What does Oyster Point Pharma do?

Oyster Point Pharma is a pharmaceuticals company.

Where is Oyster Point Pharma headquartered?

Oyster Point Pharma is headquartered in Princeton, US.

Which VCs invest in companies like Oyster Point Pharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Oyster Point Pharma's stage. Their profiles are linked below.

Raising like Oyster Point Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.